Torrent Pharmaceuticals has received board approval to raise a significant Rs 12,500 crore. This capital will be generated through the issuance of securities on a private placement basis. The company plans to issue secured, rated, listed, redeemable non-convertible debentures. This move follows a major acquisition last year. Shares of Torrent Pharma closed slightly lower on Monday.